ALC|Alcon AG|Preço:74.560|Var. %:-0.91

Mais detalhes de Alcon AG Empresa

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

Informações de Alcon AG



Código da empresaALC

Nome da EmpresaAlcon AG

Data de listagemApr 09, 2019

CEOEndicott (David J)

Número de funcionários25599

Tipo de títulosOrdinary Share

Fim do ano fiscalApr 09

EndereçoRue Louis d'Affry 6

CidadeFRIBOURG

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísSwitzerland

Código postal1700

Telefone41589113800

Sitehttps://www.alcon.ch/

Código da empresaALC

Data de listagemApr 09, 2019

CEOEndicott (David J)

Executivos da empresa Alcon AG



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. David J. Endicott

Chief Executive Officer, Director

269.77K

+23.23%

Mr. Timothy C. (Tim) Stonesifer

Chief Financial Officer, Senior Vice President

140.55K

+4.49%

Mr. Rajkumar Narayanan

Senior Vice President, President - International

48.83K

--

Mr. Ian Bell

Chief Operating Officer, Senior Vice President

47.49K

+36.34%

Ms. Karen J. May, CPA

Independent Director

41.42K

+31.62%

Mr. Laurent Attias

Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)

21.91K

-3.22%

Mr. Scott Harlan Maw

Independent Director

18.84K

+8.38%

Ms. Ines Poeschel

Independent Director

13.81K

+12.53%

Ms. Lynn Dorsey Bleil

Independent Director

12.42K

+11.96%

Ms. Deborah Di Sanzo

Director

450.00

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. David J. Endicott

Chief Executive Officer, Director

269.77K

+23.23%

Mr. Timothy C. (Tim) Stonesifer

Chief Financial Officer, Senior Vice President

140.55K

+4.49%

Mr. Rajkumar Narayanan

Senior Vice President, President - International

48.83K

--

Mr. Ian Bell

Chief Operating Officer, Senior Vice President

47.49K

+36.34%

Ms. Karen J. May, CPA

Independent Director

41.42K

+31.62%

Mr. Laurent Attias

Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)

21.91K

-3.22%

Detalhamento da receita

Moeda: USDAtualizado em: qui, 2 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Por EmpresaUSD

Nome

Receita

Proporção

Consumables

3.03B

29.34%

Contact lenses

2.77B

26.84%

Ocular health

1.80B

17.42%

Implantables

1.78B

17.27%

Equipment/other

941.00M

9.12%

Por RegiãoUSD

Nome

Receita

Proporção

United States

4.66B

45.13%

Other

4.41B

42.76%

Japan

609.00M

5.90%

China

570.00M

5.52%

Switzerland

71.00M

0.69%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Consumables

3.03B

29.34%

Contact lenses

2.77B

26.84%

Ocular health

1.80B

17.42%

Implantables

1.78B

17.27%

Equipment/other

941.00M

9.12%

Distribuição de ações

Atualizado em: sáb, 21 de fev

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Advisors (UK) Limited

4.94%

The Vanguard Group, Inc.

4.25%

Norges Bank Investment Management (NBIM)

2.41%

UBS Fund Management (Switzerland) AG

2.29%

Aristotle Capital Management, LLC

2.21%

Outro

83.89%

Investidores

Proporção

BlackRock Advisors (UK) Limited

4.94%

The Vanguard Group, Inc.

4.25%

Norges Bank Investment Management (NBIM)

2.41%

UBS Fund Management (Switzerland) AG

2.29%

Aristotle Capital Management, LLC

2.21%

Outro

83.89%

Tipos de investidores

Investidores

Proporção

Investment Advisor

29.65%

Investment Advisor/Hedge Fund

25.01%

Bank and Trust

4.17%

Hedge Fund

3.48%

Sovereign Wealth Fund

2.49%

Pension Fund

1.68%

Research Firm

1.65%

Individual Investor

0.17%

Insurance Company

0.09%

Outro

31.61%

Participação acionária institucional



Atualizado em: qua, 1 de abr

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2026Q1

1659

341.09M

68.26%

-17.12M

2025Q4

1623

342.44M

72.26%

+507.76K

2025Q3

1664

342.40M

72.42%

-9.24M

2025Q2

1658

350.50M

70.82%

+3.47M

2025Q1

1649

340.47M

77.49%

-46.78M

2024Q4

1637

370.92M

68.31%

+36.10M

2024Q3

1614

334.31M

67.55%

+3.20M

2024Q2

1581

336.83M

74.41%

-28.77M

2024Q1

1567

336.16M

66.45%

+4.09M

2023Q4

1583

325.43M

67.42%

+1.37M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Advisors (UK) Limited

24.68M

4.94%

--

Dec 31, 2025

The Vanguard Group, Inc.

21.23M

4.25%

+262.09K

+1.25%

Dec 31, 2025

Norges Bank Investment Management (NBIM)

12.05M

2.41%

+706.67K

+6.23%

Dec 31, 2025

UBS Fund Management (Switzerland) AG

11.47M

2.29%

-68.71K

-0.60%

Jun 30, 2025

Aristotle Capital Management, LLC

11.07M

2.21%

+360.01K

+3.36%

Dec 31, 2025

Zürcher Kantonalbank (Asset Management)

8.49M

1.7%

-648.99K

-7.10%

Sep 30, 2025

AKO Capital LLP

7.69M

1.54%

-287.66K

-3.61%

Dec 31, 2025

Fidelity Management & Research Company LLC

7.33M

1.47%

-125.69K

-1.69%

Dec 31, 2025

Select Equity Group, L.P.

6.22M

1.24%

-509.38K

-7.57%

Dec 31, 2025

Pictet Asset Management Ltd.

4.97M

0.99%

+161.26K

+3.36%

Dec 31, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

Global X Aging Population ETF

2.36%

Franklin FTSE Switzerland ETF

2.28%

iShares MSCI Switzerland ETF

2.2%

First Trust Indxx Medical Devices ETF

2.06%

Running Oak Efficient Growth ETF

1.77%

Global X S&P Catholic Values Developed ex-US ETF

1.07%

JPMorgan BetaBuilders Europe ETF

0.59%

iShares Global Healthcare ETF

0.53%

ALPS O'Shares International Developed Quality Dividend ETF

0.45%

Wahed Dow Jones Islamic World ETF

0.44%

Ver Mais

Global X Aging Population ETF

Proporção2.36%

Franklin FTSE Switzerland ETF

Proporção2.28%

iShares MSCI Switzerland ETF

Proporção2.2%

First Trust Indxx Medical Devices ETF

Proporção2.06%

Running Oak Efficient Growth ETF

Proporção1.77%

Global X S&P Catholic Values Developed ex-US ETF

Proporção1.07%

JPMorgan BetaBuilders Europe ETF

Proporção0.59%

iShares Global Healthcare ETF

Proporção0.53%

ALPS O'Shares International Developed Quality Dividend ETF

Proporção0.45%

Wahed Dow Jones Islamic World ETF

Proporção0.44%

Dividendo



Um total de 400.00M USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Mar 01, 2022

ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022

May 04, 2022

May 05, 2022

May 03, 2022

Feb 24, 2021

ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021

May 05, 2021

May 06, 2021

May 04, 2021

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados